Literature DB >> 9265982

Who benefits from immunotherapy?

S Bonini, G Rasi.   

Abstract

Mesh:

Substances:

Year:  1997        PMID: 9265982     DOI: 10.1111/j.1398-9995.1997.tb01224.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


× No keyword cloud information.
  2 in total

1.  [Use of specific immunotherapy in the Basic Health Area of Campiña Sur (Moguer-Huelva)].

Authors:  F J Atienza Martín; P Márquez Ramírez; R Pérez Jigato; I Pérez Errazquin; M Alonso Pérez; N López Bueno
Journal:  Aten Primaria       Date:  2000 Jul-Aug       Impact factor: 1.137

2.  Regulatory aspects of allergen-specific immunotherapy: europe sets the scene for a global approach.

Authors:  Sergio Bonini
Journal:  World Allergy Organ J       Date:  2012-10       Impact factor: 4.084

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.